CLINICAL STUDY OF BACH FLOWER REMEDIES IN GENERALISED ANXIETY DISORDER IN AGE OF ABOVE 18YRS.
Phase 3
- Conditions
- Health Condition 1: F411- Generalized anxiety disorderHealth Condition 2: F411- Generalized anxiety disorder
- Registration Number
- CTRI/2022/01/039671
- Lead Sponsor
- Dr G V GAYATRI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)All the persons fulfilling the case definition given by ICD-10; DSM-5 criteria.
2)Persons having GAD-7 Score would be greater then or equal to 10.
3)Persons who are willing to take treatment regularly and co-operate for regular follow-ups.
4)Persons belonging to above 18 years age group.
Exclusion Criteria
1)Persons requiring IPD management.
2)BELOW 18 YEARS OF AGE.
3)Persons having GAD-7 Score would be lesser than 10.
4)Severely ill or emergency cases.
5)Persons presenting with gross pathological cases.
6)Persons suffering any systemic disorder which interfere with present study will be excluded.
7)Pregnant women and related disorders.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1)To study the efficacy of Bach flower remedies for management of episodes of generalized anxiety disorder.Timepoint: Improvement according to Generalized anxiety disorder assessment 7 score and the spielberger state trait anxiety inventory (STAI Y1 AND Y2) scale on day 1 before and every follow up of 15 days for 3 months.
- Secondary Outcome Measures
Name Time Method 1)To relieve the symptoms and to improve the quality of life of patients with Generalized anxiety disorder. <br/ ><br>Timepoint: Assessment on day 1 and after 3 months.